[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Journal Information::
Articles archive::
For Authors::
For Reviewers::
Contact us::
Site Facilities::
Search in website

Advanced Search
Receive site information
Enter your Email in the following box to receive the site news and information.
:: Volume 31, Issue 3 (Fall 2021) ::
MEDICAL SCIENCES 2021, 31(3): 338-345 Back to browse issues page
Comparison of visual-spatial perception ability in patients with multiple sclerosis (MS) and normal people in Tabriz City
Hamid Zaferani Arani1 , Khalil Alimohammadzadeh2 , Negin Abbasi Garravand3 , Zahra Abbasy 4
1- Medical Student, Young Researchers and Elite Club, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran
2- Associate Professor, Department of Health Services Management, North Tehran Branch, Islamic Azad University, Tehran, Iran - Health Economics Policy Research Center, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran
3- MA Student of Psychology, Faculty of Educational Sciences and Psychology, University of Tabriz, Tabriz, Iran
4- 5Faculty of Medicine, Kashan University of Medical Sciences, Kashan, Iran
Abstract:   (1837 Views)
Background: Cognitive deficits in multiple sclerosis (MS) are frequent and debilitating. Changes in information processing speed are the most important cognitive complication in this disease. The purpose of this study was to compare visual-spatial perception ability in patients and healthy individuals.
Materials and methods: This cross-sectional study was performed in Tabriz City from April to December 2018 in a descriptive-comparative method. After screening of 280 samples included in the study, 246 healthy samples remained at the end of the study. Of these, 123 were in the patient group and 123 in the healthy group. Linear orientation evaluation (JLO) was performed on the samples. Data were analyzed and normal and patient group differences were compared.
Results: Mean age of studied samples were 0.45 ± 24.31 and 0.26 ± 23.67 for healthy and affected samples, respectively (P>0.05). 73.56% of affected patients and 79.96% of healthy subjects were married. The sex ratio of healthy samples was approximately equal (49.47% male and 51.53% female), while in the patient samples female sex was more frequent (56.74% female and 43.26% male). Visual-spatial perception ability was weaker in Patients with multiple sclerosis than healthy subjects.
Conclusion: Patients with multiple sclerosis have a poorer cognitive function than normal individuals; thus rehabilitation of these patients through better education and other measures can lead to better visual-spatial understanding.
Keywords: Cognitive function, Multiple sclerosis, Spatial vision perception, Line orientation assessment, Z score.
Full-Text [PDF 240 kb]   (1335 Downloads)    
Semi-pilot: Qualitative | Subject: Psychiatric Nursing
Received: 2021/01/25 | Accepted: 2021/04/12 | Published: 2021/09/14
1. Trapp BD, Nave KA. Multiple sclerosis: an immune or neurodegenerative disorder? Annu Rev Neurosci 2008;31:247-69. [DOI:10.1146/annurev.neuro.30.051606.094313]
2. Frohman EM, Racke MK, Raine CS. Multiple sclerosis-the plaque and its pathogenesis. N Engl J Med 2006;354:942-55. [DOI:10.1056/NEJMra052130]
3. Friese MA, Schattling B, Fugger L. Mechanisms of neurodegeneration and axonal dysfunction in multiple sclerosis. Nat Rev Neurol 2014;10:225. [DOI:10.1038/nrneurol.2014.37]
4. Kister I, Bacon TE, Chamot E, Salter AR, Cutter GR, Kalina JT, et al. Natural history of multiple sclerosis symptoms. Int J MS Care 2013;15:146-56. [DOI:10.7224/1537-2073.2012-053]
5. Chwastiak L, Ehde DM, Gibbons LE, Sullivan M, Bowen JD, Kraft GH. Depressive symptoms and severity of illness in multiple sclerosis: epidemiologic study of a large community sample. Am J Psychiatry 2002;159:1862-8. [DOI:10.1176/appi.ajp.159.11.1862]
6. Dargahi N, Katsara M, Tselios T, Androutsou ME, De Courten M, Matsoukas J, et al. Multiple sclerosis: immunopathology and treatment update. Brain Sci 2017;7:78. [DOI:10.3390/brainsci7070078]
7. Oksenberg JR, Barcellos LF. Multiple sclerosis genetics: leaving no stone unturned. Genes Immun 2005;6:375. [DOI:10.1038/sj.gene.6364237]
8. Noyes K, Bajorska A, Chappel A, Schwid SR, Mehta LR, Weinstock-Guttman B, et al. Cost-effectiveness of disease-modifying therapy for multiple sclerosis: a population-based study. Neurology 2011;77:355-63. [DOI:10.1212/WNL.0b013e3182270402]
9. S Weber M, Menge T, Lehmann-Horn K, C Kronsbein H, Zettl U, Sellner J, et al. Current treatment strategies for multiple sclerosis-efficacy versus neurological adverse effects. Curr Pharm Des 2012;18:209-19. [DOI:10.2174/138161212799040501]
10. Rudick RA, Miller DM. Health-related quality of life in multiple sclerosis. CNS Drugs 2008;22:827-39. [DOI:10.2165/00023210-200822100-00004]
11. Dilokthornsakul P, Valuck RJ, Nair KV, Corboy JR, Allen RR, Campbell JD. Multiple sclerosis prevalence in the United States commercially insured population. Neurology 2016;86:1014-21. [DOI:10.1212/WNL.0000000000002469]
12. Etemadifar M, Sajjadi S, Nasr Z, Firoozeei TS, Abtahi SH, Akbari M, et al. Epidemiology of multiple sclerosis in Iran: a systematic review. Eur Neurol 2013;70:356-63. [DOI:10.1159/000355140]
13. Giesser BS. Gender issues in multiple sclerosis. Neurologist 2002;8:351-6. [DOI:10.1097/00127893-200211000-00003]
14. MacLurg K, Reilly P, Hawkins S, Gray O, Evason E, Whittington D. A primary care-based needs assessment of people with multiple sclerosis. Br J Gen Pract 2005;55:378-83.
15. Jongen PJ, Ter AH, Brands AM. Cognitive impairment in multiple sclerosis. Minerva Medica 2012;103:73-96.
16. Lincoln NB, Dent A, Harding J, Weyman N, Nicholl C, Blumhardt LD, et al. Evaluation of cognitive assessment and cognitive intervention for people with multiple sclerosis. J Neurol Neurosurg Psychiatry 2002;72:93-8. [DOI:10.1136/jnnp.72.1.93]
17. Sartori E, Edan G. Assessment of cognitive dysfunction in multiple sclerosis. J Neurol Sci 2006;245:169-75. [DOI:10.1016/j.jns.2005.07.016]
18. Amato MP, Portaccio E, Stromillo ML, Goretti B, Zipoli V, Siracusa G, et al. Cognitive assessment and quantitative magnetic resonance metrics can help to identify benign multiple sclerosis. Neurology 2008;71:632-8. [DOI:10.1212/01.wnl.0000324621.58447.00]
19. Benton AL, Varney NR, Hamsher KD. Visuospatial judgment: A clinical test. Arch Neurol 1978;35:364-7. [DOI:10.1001/archneur.1978.00500300038006]
20. Spencer RJ, Wendell CR, Giggey PP, Seliger SL, Katzel LI, Waldstein SR. Judgment of Line Orientation: an examination of eight short forms. J Clin. Exp Neuropsychol 2013;35:160-6. [DOI:10.1080/13803395.2012.760535]
21. Cheadle C, Vawter MP, Freed WJ, Becker KG. Analysis of microarray data using Z score transformation. J Mol Diagn 2003;5:73-81. [DOI:10.1016/S1525-1578(10)60455-2]
22. Benesty J, Chen J, Huang Y, Cohen I. Pearson correlation coefficient. In: Cohen I, Huang Y, Chen J, Benesty J, Editors. Noise reduction in speech processing. Berlin, Heidelberg: Springer; 2009. P.1-4. [DOI:10.1007/978-3-642-00296-0_5]
23. Bobholz JA, Rao SM. Cognitive dysfunction in multiple sclerosis: a review of recent developments. Curr Opin Neurol 2003;16:283-8. [DOI:10.1097/01.wco.0000073928.19076.84]
24. Mowry EM, Loguidice MJ, Daniels AB, Jacobs DA, Markowitz CE, Galetta SL, et al. Vision related quality of life in multiple sclerosis: correlation with new measures of low and high contrast letter acuity. J Neurol Neurosurg Psychiatry 2009;80:767-72. [DOI:10.1136/jnnp.2008.165449]
25. Smerbeck AM, Parrish J, Serafin D, Yeh EA, Weinstock-Guttman B, Hoogs M, et al. Visual-cognitive processing deficits in pediatric multiple sclerosis. Mult Scler J 2011;17:449-56. [DOI:10.1177/1352458510391689]
26. Yalachkov Y, Bergmann J, Soydaş D, Buschenlange C, Fadai Motlagh LY, Naumer MJ, et al. Cognitive impairment in multiple sclerosis is reflected by increased susceptibility to the sound-induced flash illusion. Front Neurol 2019;10:373. [DOI:10.3389/fneur.2019.00373]
27. Rahn K, Slusher B, Kaplin A. Cognitive impairment in multiple sclerosis: a forgotten disability remembered. Cerebrum 2012;2012:14.
28. Chiaravalloti ND, DeLuca J. Cognitive impairment in multiple sclerosis. Lancet Neurol 2008;7:1139-51. [DOI:10.1016/S1474-4422(08)70259-X]
29. Lazeron RH, Boringa JB, Schouten M, Uitdehaag BM, Bergers E, Lindeboom J, et al. Brain atrophy and lesion load as explaining parameters for cognitive impairment in multiple sclerosis. Mult Scler J 2005;11:524-31. [DOI:10.1191/1352458505ms1201oa]
30. Svendsen B, Grytten N, Bø L, Aarseth H, Smedal T, Myhr KM. The economic impact of multiple sclerosis to the patients and their families in Norway. Eur J Health Econ 2018;19:1243-57. [DOI:10.1007/s10198-018-0971-5]
Add your comments about this article
Your username or Email:


XML   Persian Abstract   Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Zaferani Arani H, Alimohammadzadeh K, Abbasi Garravand N, Abbasy Z. Comparison of visual-spatial perception ability in patients with multiple sclerosis (MS) and normal people in Tabriz City. MEDICAL SCIENCES 2021; 31 (3) :338-345
URL: http://tmuj.iautmu.ac.ir/article-1-1759-en.html

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 31, Issue 3 (Fall 2021) Back to browse issues page
فصلنامه علوم پزشکی دانشگاه آزاد اسلامی واحد پزشکی تهران Medical Science Journal of Islamic Azad Univesity - Tehran Medical Branch
Persian site map - English site map - Created in 0.05 seconds with 37 queries by YEKTAWEB 4624